Provided by Tiger Trade Technology Pte. Ltd.

Natera

326.01
-0.1350-0.04%
Volume:116.92K
Turnover:38.28M
Market Cap:46.69B
PE:-237.46
High:330.18
Open:330.18
Low:324.45
Close:326.14
52wk High:343.18
52wk Low:157.43
Shares:143.22M
Float Shares:139.00M
Volume Ratio:1.08
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3729
EPS(LYR):-1.5269
ROE:-12.54%
ROA:-8.08%
PB:25.63
PE(LYR):-213.51

Loading ...

5 Healthcare Stocks That Are Poised To Ride AI to Gains -- Barrons.com

Dow Jones
·
Jun 07

Natera CEO Steven Chapman disposes of shares worth $7.49 million

Reuters
·
Jun 06

Natera Expands Board, Appoints Thomas Lynch as Director

TIPRANKS
·
Jun 06

Healthcare Stocks Can Benefit From AI, Too. But That Isn't the Reason to Buy Them. -- Barrons.com

Dow Jones
·
Jun 05

Natera Initiated at Neutral by Goldman Sachs

Dow Jones
·
Jun 05

Natera initiated with a Neutral at Goldman Sachs

TIPRANKS
·
Jun 05

Movement Alert|Natera Rises 5.5% in Regular Trading, Signatera Platform Secures Multiple Clinical Collaborations

Market Focus
·
Jun 04

Natera, CytoDyn collaborate to advance ctDNA-guided development

TIPRANKS
·
Jun 04

Natera partners with CytoDyn on ctDNA analysis for metastatic colorectal cancer study

Reuters
·
Jun 04

Natera President, Clinical Diagnostics Solomon Moshkevich sells USD 652,083.87 in common shares

Reuters
·
Jun 04

Natera director Roelof Botha disposes of 78,000 common shares worth $17.2 million

Reuters
·
Jun 04

Natera appoints oncologists Thomas Lynch, Eric Rubin to board

Reuters
·
Jun 03

Natera Appoints Oncology Leaders DRS. Thomas Lynch and Eric Rubin to Board of Directors

THOMSON REUTERS
·
Jun 03

Natera Coverage Assumed by Wolfe Research at Outperform

Dow Jones
·
Jun 02

Natera assumed with an Outperform at Wolfe Research

TIPRANKS
·
Jun 02

U.S. Supreme Court rejects Natera, CareDx false-advertising dispute

Reuters
·
Jun 02

CareDx denied request to Supreme Court to revive Natera award

TIPRANKS
·
Jun 02

Natera partners with Diakonos Oncology to use Signatera in refractory melanoma trial

Reuters
·
May 29

Natera Announces Collaboration With Diakonos Oncology for Signatera™ in Refractory Melanoma

THOMSON REUTERS
·
May 29

Natera Enrolls First Patients in Study Evaluating MRD-Guided Therapy for Breast Cancer

MT Newswires Live
·
May 28